David Drutz - Dec 14, 2021 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ William Brown, as Attorney-in-Fact
Stock symbol
ALT
Transactions as of
Dec 14, 2021
Transactions value $
$334
Form type
4
Date filed
12/15/2021, 06:00 PM
Previous filing
Nov 19, 2021
Next filing
Feb 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Options Exercise $334 +139 +0.79% $2.40 17.8K Dec 14, 2021 Direct
holding ALT Common Stock, par value $0.0001 333 Dec 14, 2021 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALT Stock Options (option to buy) Options Exercise $0 -139 -100% $0.00* 0 Dec 14, 2021 Common Stock, par value $0.0001 139 $2.40 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.
F2 This option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split reverse stock split that occurred on September 13, 2018.
F3 This option is fully vested and exercisable as of the date hereof.